68Ga-FAPI PET/CT鉴别鼻咽癌反应性淋巴结与转移性淋巴结
本文报道一例鼻咽癌患者,18F-FDG PET/CT和MRI均误判为双侧颈部淋巴结转移,但病理证实为反应性增生无肿瘤转移;68Ga-FAPI PET/CT在非转移反应性淋巴结中未见异常摄取,提示其可能有助于鼻咽癌治疗前淋巴结状态评估。
要点
- 18F-FDG PET/CT和MRI可误判鼻咽癌颈部反应性淋巴结为转移。
- 68Ga-FAPI PET/CT在反应性淋巴结中未见异常摄取。
- 68Ga-FAPI PET/CT或有助于鼻咽癌治疗前淋巴结状态评估。
核心结论
- 68Ga-FAPI PET/CT可能有助于评估鼻咽癌治疗前淋巴结状态,避免因假阳性误判导致的非必要化疗。
研究设计与样本
- 本文为个案报道,描述一例鼻咽癌患者的影像与病理对照结果。
主要发现
- 该患者经18F-FDG PET/CT和MRI均被误诊为双侧颈部淋巴结转移。
- 病理结果显示淋巴结内为增殖的淋巴细胞,无肿瘤转移迹象。
- 68Ga-FAPI PET/CT在非转移的反应性淋巴结中未见异常摄取。
临床怎么用
- 对鼻咽癌患者治疗前淋巴结状态评估,可考虑68Ga-FAPI PET/CT以减少反应性淋巴结的假阳性判读。
局限性
- 本文仅为单例个案报道,结论需更大样本研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Accurate clinical staging is crucial for managing nasopharyngeal carcinoma (NPC). However, false-positive finding of cervical lymph nodes in 18F-FDG PET/CT and MRI may lead to unnecessary chemotherapy for NPC. In this case, we report a patient with NPC who was incorrectly diagnosed with bilateral cervical lymph node metastases by both 18F-FDG PET/CT and MRI. Subsequent pathology results showed proliferating lymphoid cells with no signs of tumor metastasis. Interestingly, no abnormal 68Ga-FAPI uptake was observed in the nonmetastatic reactive lymph nodes. Therefore, 68Ga-FAPI PET/CT may be useful for assessment of pretreatment lymph node status in NPC.
引用
- Shang Q, Zhao L, Pang Y, et al. 68Ga-FAPI PET/CT Distinguishes the Reactive Lymph Nodes From Tumor Metastatic Lymph Nodes in a Patient With Nasopharyngeal Carcinoma. Clin Nucl Med. 2022. PMID: 34653051. doi:10.1097/RLU.0000000000003939
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。